Lowest Price Guaranteed
Pages
560
Last Updated
January 2026
View Count
21767
The global medical device CRO market, valued at USD 20.4 billion in 2025, is projected to grow to USD 22.0 billion in 2026 and USD 43.6 billion by 2035, representing a CAGR of 7.9% during the forecast period 2026 to 2035.
To learn more about this report, request a free sample copy
Through our new market research study, we have identified the key market trends, competitive landscape, market forecast and opportunity for medical device contract research organizations (CRO). The growth of medical device CRO market over the next decade is expected to be driven by continuous technological advancements leading to the development of complex and innovative medical devices, which, in turn, necessitates stringent regulatory review.
 |
 |
 |
In recent years, there has been a notable increase in the number of clinical trials focused on medical devices. This surge is driven by the need for rigorous testing of innovative medical devices, which highlights the importance of CROs. These organizations offer specialized expertise in areas, such as following good clinical practices and generating / providing real world evidence (to assess the safety and efficacy of medical device).
As technology continues to evolve, medical devices are becoming more intricate, prompting the medical device companies to seek support from CROs for preclinical and clinical research in order to navigate regulatory affairs and conduct clinical trials. Together, these factors are anticipated to drive market growth.
Medical device is defined as an apparatus, instrument or machine designed to monitor and treat patients across various target indications. According to the United States Food Drug and Administration (USFDA), a medical device is an instrument intended for use in diagnosis, and disease prevention / mitigation; these devices do not achieve their primary function through chemical action within or on the body. Further, as per the World Health Organization (WHO), currently there are close to 2 million types of medical devices (including in vitro diagnostics) categorized into approximately 7,000 generic device groups worldwide. Over the past decade, the medical device industry has experienced a surge in research and innovation, fueled by numerous scientific and technological breakthroughs. This increased pace of innovation coupled with the increasing disease burden on healthcare system is driving the demand for advanced medical devices, including autoinjectors, connected drug delivery devices, needle free drug delivery devices and ultrasound devices.
 |
 |
 |
Despite the growing emphasis on clinical trials focused on medical devices in recent years, only a few medical device companies claim to have the required technical expertise to conduct comprehensive in-house full service operations, including preclinical and clinical research. The substantial costs of establishing the necessary infrastructure and the requirement of skilled expertise create a challenging environment for medical device companies to conduct preclinical and clinical research studies in-house, resulting in outsourcing their product development operations to service providers. For instance, in December 2024, Sunway Healthcare entered into a strategic collaboration with Syneos Health (a medical CRO) in order to expand its clinical trial capabilities (including operational efficiencies and patient access) across multiple therapeutic areas in Malaysia.
Notably, the stringent regulatory guidelines governing the quality assurance of medical devices pose significant challenges for industry leaders, particularly those with limited financial resources, in conducting preclinical and clinical research studies. It is important to highlight that, post COVID-19 pandemic, a substantial increase in the demand for home healthcare medical devices has been observed. These devices are usually embedded with advanced features and sensors along with wireless connectivity capabilities (primarily facilitated through Bluetooth, near field communication, Wi-Fi or cellular networks), enabling seamless integration with mobile applications, digital health platforms and electronic data capture.
 |
 |
 |
The demand for advanced medical devices has intensified the pressure on medical device companies to not only meet rigorous regulatory standards but also expand their product offerings. Driven by the above-mentioned factors, several small and well-established players are increasingly outsourcing full service operations related to clinical operations and management of regulatory requirements to service providers. This allows the medical device companies to leverage the expertise of CROs in navigating complex regulatory affairs and conducting clinical trials efficiently, allowing them to focus on innovation and market expansion.
The market report presents an in-depth analysis of the various medical device CROs, across different segments, as defined in the table below:
| Key Report Attributes | Details | |
| Historical Trends | Since 2019 | |
| Forecast Period | Till 2035 | |
| Current Market Size | $22.0 Billion | |
| Market Size 2035 | $43.6 Billion | |
| CAGR till 2035 | 7.9% | |
| Class of Medical Device |
|
|
| Type of Medical Device |
|
|
| Scale of Operation |
|
|
| Type of Preclinical Service Offered |
|
|
| Type of Clinical Service Offered |
|
|
| Company Size |
|
|
| Type of Original Equipment Manufacturer |
|
|
| Target Indication |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
|
|
One of the key objectives of the medical device CRO market report is to estimate the current market size, opportunity and the future growth potential of the market, over the forecast period.
The medical device CRO market analysis also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as distribution by class of medical device (class I, class II and class III medical devices), type of medical device (MedTech devices, diagnostic devices, handheld diagnostic devices and other devices), scale of operation (preclinical and clinical), type of preclinical service offered (sterility and microbiology testing, biocompatibility testing, material characterization and analytical testing and other services), type of clinical service offered (clinical trial management, data management, regulatory support, consultancy and other services), company size (small, mid-sized, large and very large), type of original equipment manufacturer (small and mid-sized CROs, large CROs and very large CROs), target indication (cardiovascular disorders, oncological disorders, neurological disorders, orthopedic disorders, pain disorders, ophthalmological disorders, psychological disorders, metabolic disorders and other disorders), geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America).
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The market report features detailed transcripts of interviews conducted with the following individuals:
Further, all actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market report are in USD, unless otherwise specified.
Based on the class of medical device, the global medical device CRO market is segmented into class I, class II and class III medical devices. It is worth mentioning that currently, the class II medical devices segment occupies the highest share in the overall market. However, the class III segment is expected to witness substantial market growth during the forecast period. This can be attributed to the fact that medical device companies tend to outsource the development of their class III medical, since these devices are high-risk devices.
These devices have the potential to cause serious illness or injury to the user (in case of failure) and are subjected to more stringent regulatory requirements than class I and class II medical devices.
The global market is categorized across various types of medical devices, such as MedTech devices, diagnostic devices, handheld diagnostic devices and other devices. Currently, MedTech devices segment occupies the largest medical device CRO market share. Further, it is worth highlighting that diagnostic device market segment is likely to grow at a relatively higher CAGR during the forecast period.
Notably, post COVID-19, there has been a significant shift towards at-home diagnostic devices. These devices are directly operated by individuals themselves and allow them to monitor and manage information about their health status. As a result, CROs are leveraging various advanced technologies (including digital therapeutics, data analytics, and telemedicine capabilities) in clinical trials for more efficient data collection and patient monitoring.
The global medical device CRO market is segmented across different scales of operations, namely preclinical and clinical scale. The current market is dominated by the revenues generated through clinical studies of medical devices and is expected to continue dominating the market, during the forecast period. This can be attributed to the fact that clinical research studies are more resource intensive as these studies require larger patient population and diverse study designs, which necessitates extensive planning, execution, and monitoring.
Based on the type of preclinical service, the global market is segmented across biocompatibility testing, sterility and microbiology testing, material characterization and analytical testing, and other services. Currently, the sterility and microbiology segment is expected to hold the majority medical device CRO market share and this trend is unlikely to change during the forecast period. Further, it is important to mention that biocompatibility testing market segment is likely to grow at a relatively higher CAGR during the forecast period.
Based on the type of clinical service, the global medical device CRO market is segmented into clinical trial management, data management, regulatory support, consultancy and other services. It is important to mention that currently, the clinical trial management segment occupies the highest share in the overall market. Further, the consultancy segment is expected to witness substantial market growth during the forecast period.
Notably, through consulting services, the clinical research organizations provide specialized expertise in various key aspects of clinical research, such as clinical data management, post-marketing surveillance and regulatory strategies. By leveraging these services, medical device companies can optimize the clinical trials process efficiently and ensure the safety of medical devices reaching the market.
The global market is segmented across various types of company size, namely small, mid-sized and large companies. Currently, the market for large companies is expected to hold the majority medical device CRO market share and this trend is unlikely to change during the forecast period. This can be attributed to the fact that large companies often possess extensive infrastructure, well-established distribution networks and have easy access to advanced technologies.
The global medical device CRO market is categorized across various original equipment manufacturers, such as small and mid-sized CROs, large CROs and very large CROs. Currently, very large CROs segment occupies the largest share in the overall market. Further, it is worth highlighting that segment for mid-sized CROs is likely to grow at a relatively higher CAGR during the forecast period.
The global market is segmented across different target indications, namely cardiovascular disorders, oncological disorders, neurological disorders, orthopedic disorders, pain disorders, ophthalmological disorders, psychological disorders, metabolic disorders and other disorders. Notably, revenues generated through cardiovascular disorders is expected to hold the majority medical device CRO market share in the current year.
Presently, cardiovascular disorders are the leading cause of mortality across the globe. This in turn, has resulted in the heightened demand for cardiovascular devices, such as angioplasty devices, pacemakers and stents. As a result, the healthcare industry has shifted its focus towards advanced cardiovascular devices, for the efficient diagnosis and treatment of these conditions.
This segment highlights the distribution of overall market across various geographies, such as North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America. Presently, North America is estimated to capture majority of the medical device CRO market share, and this trend is unlikely to change in the future as well.
It is worth highlighting that the market in Asia-Pacific is expected to grow at a relatively higher CAGR, during the forecast period, till 2035. This can be primarily attributed to the increasing regulatory requirements for the approval of medical devices in this region. Notably, some of the Asian countries, follow the risk-based classification systems for medical devices, wherein class II and III medical devices are subjected to more stringent requirements. As a result, it is imperative for medical device companies to conduct human factors and usability engineering of their medical devices.
The “Medical Device CRO Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size and future opportunities within the medical device CRO industry, during the given forecast period. The market report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the medical devices market. Key takeaways of the market report have been briefly discussed below.
The integration of digital tools, such as software applications, cloud computing platforms or data-gathering sensors in medical devices offer several advantages, including seamless machine-to-machine communication. These connected medical devices are anticipated to generate large volume of healthcare data, which can be transmitted to cloud and healthcare IT systems for remote / local storage and analysis.
As a result, many hospitals / healthcare institutions are increasingly focusing on fostering interoperability between data generated by medical devices and electronic health records, as it is a critical aspect for creating patient-centered and digitally enabled healthcare environment. Therefore, many CROs are now offering cloud-based solutions for clinical applications in order to enable real-time study management.
In fact, numerous collaborations and acquisition agreements have been signed between CROs and data management / digital technology solution providers in the recent past. These partnerships are likely to help CROs expand their capabilities and remain competitive in the industry in the foreseen future.
During our research, we came across close to 110 medical device CROs offering preclinical services related to medical devices; the services include regulatory / certification services, material characterization and analytical services, toxicology, feasibility, biocompatibility testing, preclinical strategy, sterility and microbiology testing, pharmacokinetics and package integrity testing. Further, it is important to highlight that the medical devices preclinical CRO industry is dominated by small companies, followed by mid-sized companies, having the required expertise to offer preclinical services across the globe.
The current market landscape features close to 330 companies that claim to have the required expertise to provide clinical services for medical devices, across various geographical regions. Notably, 32% of the medical device CROs offer clinical research services for all classes of medical devices (class I, class II and class III). In addition, close to 90% of the medical devices clinical CROs claim to offer consulting services to medical device companies, closely followed by training and post-market surveillance of medical devices.
In recent years, several medical device CROs have entered into various merger / acquisition deals with other players, in order to consolidate their presence in this field. It is worth highlighting that nearly majority of deals were forged in the past two years. Interestingly, most of the agreements were acquisitions, followed by mergers.
For instance, in September 2024, Eurofins Scientific completed the acquisition of Infinity Laboratories, in order to further strengthen its position in the biopharmaceutical, life sciences and medical device testing market. As stated by Dr. Gilles Martin (Chief Executive Officer, Eurofins Scientific), “We are very pleased to welcome Infinity’s teams to Eurofins. The addition of Infinity’s laboratories and competencies to Eurofins’ leading BioPharma Services network of companies further increases our leadership in providing the most innovative, high-quality and cost-competitive services and IT systems to our clients.” We anticipate that the trend of rising merger and acquisitions activity in the medical device CRO sector will continue to persist as companies respond positively to the evolving market demands and regulatory challenges.
Currently, more than 45% of the overall market is captured by North America, followed by Europe. This can be attributed to North America’s streamlined clinical trial process for product development and approval. Additionally, the well-established healthcare infrastructure and robust R&D activities conducted by industry stakeholders to advance medical device technologies, further drives market growth in this region.
However, in Asia-Pacific, the market is expected to exhibit significant growth potential, growing at a higher CAGR during the forecast period. This growth can be attributed to several factors, such as the increasing support from government organizations for the development of novel medical devices, increasing expenditure on healthcare infrastructure and rising partnerships between industry players.
Examples of medical device contract research organizations (which have also been profiled in this market report; the complete list of companies is available in the full report) include Avania, Charles River Laboratories, CROMSOURCE, CSSi LifeSciences, Eurofins Medical Testing, IQVIA, Medpace, NAMSA, Qserve and WuXi AppTec.
The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders in this industry, across different geographies. Amongst other elements, the market report includes:
Several recent developments have taken place in the medical device CRO industry, some of which have been outlined below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that we have outlined in our analysis.